{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:10:51Z","timestamp":1792757451746,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Although dolutegravir (DTG) has a favorable metabolic profile, it has been linked to excess weight gain. We evaluated changes in hepatic steatosis in adolescents with perinatally acquired HIV switching to DTG-containing antiretroviral therapy (ART).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Virologically suppressed adolescents switched to dolutegravir for a minimum of 4 months or on unchanged ART (84% protease inhibitor) were assessed prospectively with anthropometry, transient elastography with controlled attenuation parameter (CAP) and fasting metabolic profiles. ART regimens were determined independently of the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total 68 adolescents [baseline median age 13.5 years [interquartile range (IQR): 12.5\u201314.4 years]; 42 (62%) female] were recruited. However, 38 remained on the same regimen and were followed for a median of 98 weeks (IQR: 48\u2013108 weeks), and 30 switched to DTG and were followed for a median of 52 weeks (IQR: 49\u2013101). There was no baseline difference in CAP between groups. There was no significant change in body mass index z-score in either group, but the median CAP in the DTG group decreased by \u221240dB\/m (IQR: \u221251 to \u221231 dB\/m) after a median of 44 weeks (IQR: 28\u201350 weeks) on DTG, compared to +1dB\/m (IQR: \u221229 to +14 dB\/m) in adolescents not switched (<jats:italic toggle=\"yes\">P &lt; 0<\/jats:italic>.01). Cholesterol and triglycerides were lower in those switched. Whereas hepatic steatosis prevalence decreased from 17% to 3% in adolescents who switched to dolutegravir, its prevalence doubled from 8% to 16% in those not switched (<jats:italic toggle=\"yes\">P =<\/jats:italic> 0.1).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this exploratory study, adolescents switched to DTG-containing regimens had reduced hepatic steatosis, cholesterol and triglycerides with no excess weight gain compared to those on unchanged ART.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003904","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T15:00:46Z","timestamp":1678806046000},"page":"564-572","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-9227","authenticated-orcid":false,"given":"Penelope C.","family":"Rose","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-8902","authenticated-orcid":false,"given":"Etienne","family":"De la Rey Nel","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2559-6034","authenticated-orcid":false,"given":"Mark F.","family":"Cotton","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"},{"name":"Family Center for Research with Ubuntu (FAMCRU), Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-4383","authenticated-orcid":false,"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"},{"name":"School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-3301","authenticated-orcid":false,"given":"Sara H.","family":"Browne","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-3128","authenticated-orcid":false,"given":"Lisa J.","family":"Frigati","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-2963","authenticated-orcid":false,"given":"Helena","family":"Rabie","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3969-8680","authenticated-orcid":false,"given":"Steve","family":"Innes","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa"},{"name":"Family Center for Research with Ubuntu (FAMCRU), Cape Town, South Africa"},{"name":"Desmond Tutu HIV Centre, University of Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S2352-3018(15)00179-4","article-title":"Liver disease in patients with HIV in sub-Saharan Africa.","volume":"2","author":"Cainelli","year":"2015","journal-title":"Lancet HIV"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection.","volume":"377","author":"Joshi","year":"2011","journal-title":"Lancet"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus.","volume":"166","year":"2006","journal-title":"Arch Intern Med"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.27710","article-title":"A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus\/acquired immune deficiency syndrome.","volume":"61","author":"Sonderup","year":"2015","journal-title":"Hepatology"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0000000000002161","article-title":"A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.","volume":"33","author":"Kapoor","year":"2019","journal-title":"AIDS"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QAI.0b013e318074efe3","article-title":"HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients.","volume":"45","author":"Mohammed","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV\u2010infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2334-10-116","article-title":"Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.","volume":"10","author":"Dallapiazza","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40121-018-0229-7","article-title":"A review of non-alcoholic fatty liver disease in HIV-infected patients: the next big thing?","volume":"8","author":"Welzen","year":"2019","journal-title":"Infect Dis Ther"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000002127","article-title":"Liver Fibrosis in HIV Patients Receiving a Modern cART.","volume":"94","author":"Mohr","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"e25201","DOI":"10.1002\/jia2.25201","article-title":"Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.","volume":"21","author":"Perazzo","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MPG.0b013e3181a15b72","article-title":"Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.","volume":"49","author":"Rubio","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/infdis\/jiz096","article-title":"Increased prevalence of hepatic steatosis in young adults with lifelong HIV.","volume":"220","author":"Aepfelbacher","year":"2019","journal-title":"J Infect Dis"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e0226375","DOI":"10.1371\/journal.pone.0226375","article-title":"Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.","volume":"14","author":"Sudjaritruk","year":"2019","journal-title":"PLoS One"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/QAD.0000000000003170","article-title":"Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents and youths living with HIV.","volume":"36","author":"Carrasco","year":"2022","journal-title":"AIDS"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofaa195","article-title":"Factors associated with weight gain in people treated with dolutegravir.","volume":"7","author":"Taramasso","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to Treat HIV.","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofab308","article-title":"Integrase strand transfer inhibitors and weight gain in children and youth with perinatal human immunodeficiency virus in the DC cohort.","volume":"8","author":"Koay","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"e215E215","DOI":"10.1097\/INF.0000000000003076","article-title":"Increase in body mass index in children with HIV, switched to tenofovir alafenamide fumarate or dolutegravir containing antiretroviral regimens.","volume":"40","author":"Yeoh","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.1093\/cid\/ciaa1652","article-title":"Transition to dolutegravir is associated with an increase in the rate of body mass index change in a cohort of virally suppressed adolescents.","volume":"73","author":"Thivalapill","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa2108793","article-title":"Dolutegravir as first- or second-line treatment for HIV-1 infection in children.","volume":"385","author":"Turkova","year":"2021","journal-title":"N Engl J Med"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"1011161","DOI":"10.1016\/j.eclinm.2021.101116","article-title":"Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).","volume":"40","author":"Bischoff","year":"2021","journal-title":"eClinicalMedicine"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0b013e31812e56ff","article-title":"Liver stiffness measurement in children using fibroscan: feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.","volume":"45","author":"De Ledinghen","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPG.0b013e31826f2760","article-title":"Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic.","volume":"56","author":"Fitzpatrick","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jpeds.2013.04.044","article-title":"Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: The Boston Children\u2019s Hospital Experience.","volume":"163","author":"Lee","year":"2013","journal-title":"J Pediatr"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00431-011-1558-7","article-title":"Feasibility study and control values of transient elastography in healthy children.","volume":"171","author":"Engelmann","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpeds.2016.03.021","article-title":"Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients.","volume":"173","author":"Desai","year":"2016","journal-title":"J Pediatr"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan \u00ae.","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.","volume":"32","author":"De Ledinghen","year":"2012","journal-title":"Liver Int"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-017-0617-6","article-title":"Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.","volume":"17","author":"Ferraioli","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"R32-20250614","first-page":"1388","article-title":"Clinical practice guidelines EASL \u2013 EASD \u2013 easo clinical practice guidelines for the management of non-alcoholic fatty liver disease q.","volume":"64","author":"Association","year":"2019","journal-title":"J Hepatol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN.","volume":"54","author":"Vajro","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease.","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R35-20250614","first-page":"29","article-title":"Guidelines for the use of transient elastography in South Africa.","author":"Sonderup","year":"2019","journal-title":"S Afr Gastroenterol Rev"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure.","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents.","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Heal Organ"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5551\/jat.10.186","article-title":"Assessment of LDL particle size by triglyceride\/ HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia.","volume":"10","author":"Maruyama","year":"2002","journal-title":"J Atheroscler Thromb"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/diacare.23.11.1679","article-title":"Ratio of triglycerides to HDL cholesterol is an indicator of LDL sarticle size in patients with type 2 diabetes and normal HDL cholesterol levels.","volume":"23","author":"Boizel","year":"2000","journal-title":"Diabetes Care"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.","volume":"138","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"R45-20250614","first-page":"109","article-title":"Application and limitations of transient liver elastography in children.","volume":"57","author":"Goldschmidt","year":"2013","journal-title":"JPGN"},{"key":"R46-20250614","first-page":"706","article-title":"Normal liver stiffness values in children: a comparison of three different elastography methods.","volume":"68","author":"Mjelle","year":"2019","journal-title":"JPGN"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography q.","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cgh.2020.10.018","article-title":"Expert panel review on nonalcoholic fatty liver disease in persons with human immunodeficiency virus.","volume":"20","author":"Lake","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1097\/QAD.0000000000001980","article-title":"Metabolic effects of initiating lopinavir\/ ritonavir-based regimens among young children.","volume":"32","author":"Patel","year":"2018","journal-title":"AIDS"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.","volume":"31","author":"Maurice","year":"2017","journal-title":"AIDS"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.893579","article-title":"Prevalence and risk factors for hepatic steatosis in children with perinatal HIV on early antiretroviral therapy compared to HIV-exposed uninfected and HIV-unexposed children.","volume":"10","author":"Rose","year":"2022","journal-title":"Front Pediatr"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jhep.2012.12.003","article-title":"Review A 360-degree overview of paediatric NAFLD: Recent insights.","volume":"58","author":"Nobili","year":"2013","journal-title":"J Hepatol"},{"key":"R53-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/QCO.0000000000000344","article-title":"Managing nonalcoholic fatty liver disease in patients living with HIV.","volume":"30","author":"Tafesh","year":"2017","journal-title":"Curr Opin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:04:56Z","timestamp":1749945896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003904","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}